These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28356941)

  • 21. BNIP3 overexpression may promote myeloma cell apoptosis by enhancing sensitivity to bortezomib via the p38 MAPK pathway.
    Xiao P; Chen X; Dong Z; Fan W; Chen Y; Su J; Wang Q; Ma L
    Hematology; 2023 Dec; 28(1):2231739. PubMed ID: 37401850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peripheral blood exosomes from patients with multiple myeloma mediate bortezomib resistance in cultured multiple myeloma cells].
    Tang J; Chen Q; Zhang F; Zhang W; Duan S; Xiao D
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Apr; 39(4):485-489. PubMed ID: 31068294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance.
    Kim A; Seong KM; Kang HJ; Park S; Lee SS
    Oncotarget; 2015 Nov; 6(35):38225-38. PubMed ID: 26517678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.
    Salem K; Brown CO; Schibler J; Goel A
    Exp Hematol; 2013 Feb; 41(2):209-18. PubMed ID: 23063726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [IL-6 Regulates the Chemosensitivity of Drug-Resistant Multiple Myeloma Cell Lines to Bortezomib through STAT3/Notch Signaling Pathway].
    Liu Y; Sui JZ; Zhu LH; Dai Y; Dong HQ; Cheng P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1474-1481. PubMed ID: 36208252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BDNF/TrkB confers bortezomib resistance in multiple myeloma by inducing BRINP3.
    Bao L; Wang Y; Lu M; Shi L; Chu B; Gao S
    Biochim Biophys Acta Gen Subj; 2023 Mar; 1867(3):130299. PubMed ID: 36565997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined Effect of Bortezomib and Homoharringtonine on K562 Cells and their Mechanisms].
    Xie C; Tang AP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):395-400. PubMed ID: 29665904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to Bortezomib.
    Łuczkowska K; Kulig P; Baumert B; Machaliński B
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bortezomib resistance in multiple myeloma is associated with increased serine synthesis.
    Zaal EA; Wu W; Jansen G; Zweegman S; Cloos J; Berkers CR
    Cancer Metab; 2017; 5():7. PubMed ID: 28855983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.
    Voutsadakis IA; Patrikidou A; Tsapakidis K; Karagiannaki A; Hatzidaki E; Stathakis NE; Papandreou CN
    Int J Colorectal Dis; 2010 Jul; 25(7):795-804. PubMed ID: 20397022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells.
    Tibullo D; Giallongo C; Romano A; Vicario N; Barbato A; Puglisi F; Parenti R; Amorini AM; Wissam Saab M; Tavazzi B; Mangione R; Brundo MV; Lazzarino G; Palumbo GA; Volti GL; Raimondo FD; Lazzarino G
    Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of CCL2 via ATF3/c-Jun interaction mediated the Bortezomib-induced peripheral neuropathy.
    Liu C; Luan S; OuYang H; Huang Z; Wu S; Ma C; Wei J; Xin W
    Brain Behav Immun; 2016 Mar; 53():96-104. PubMed ID: 26554515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of hsa_circ_0003489 shifts balance from autophagy to apoptosis and sensitizes multiple myeloma cells to bortezomib via miR-874-3p/HDAC1 axis.
    Tian FQ; Chen ZR; Zhu W; Tang MQ; Li JH; Zhang XC; Jiang J; Cheng XH
    J Gene Med; 2021 Sep; 23(9):e3329. PubMed ID: 33625798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe.
    Hu L; Li B; Chen G; Song D; Xu Z; Gao L; Xi M; Zhou J; Li L; Zhang H; Feng Q; Wang Y; Lu K; Lu Y; Bu W; Wang H; Wu X; Zhu W; Shi J
    J Exp Clin Cancer Res; 2020 Jun; 39(1):105. PubMed ID: 32517809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spliced XBP1 Levels Determine Sensitivity of Multiple Myeloma Cells to Proteasome Inhibitor Bortezomib Independent of the Unfolded Protein Response Mediator GRP78.
    Borjan B; Kern J; Steiner N; Gunsilius E; Wolf D; Untergasser G
    Front Oncol; 2019; 9():1530. PubMed ID: 32039016
    [No Abstract]   [Full Text] [Related]  

  • 36. Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth.
    Qu FL; Xia B; Li SX; Tian C; Yang HL; Li Q; Wang YF; Yu Y; Zhang YZ
    Cancer Biol Med; 2015 Dec; 12(4):401-8. PubMed ID: 26779377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin suppresses growth of human gastric carcinoma cell by inhibiting survivin expression.
    Yang L; Zhu H; Liu D; Liang S; Xu H; Chen J; Wang X; Xu Z
    J Biomed Res; 2011 Jul; 25(4):246-53. PubMed ID: 23554697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma.
    Lipchick BC; Utley A; Han Z; Moparthy S; Yun DH; Bianchi-Smiraglia A; Wolff DW; Fink E; Liu L; Furdui CM; Lee J; Lee KP; Nikiforov MA
    Blood Adv; 2021 Apr; 5(7):1933-1946. PubMed ID: 33821992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma.
    Wu X; Xia J; Zhang J; Zhu Y; Wu Y; Guo J; Chen S; Lei Q; Meng B; Kuang C; Feng X; He Y; Shen Y; Li X; Qiu L; Li G; Zhou W
    Br J Haematol; 2020 Jul; 190(1):52-66. PubMed ID: 32037523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro synergistic effect of bortezomib and pirarubicin on proliferation and apoptosis of T cell lymphoma cell line Hut-78 cells].
    Qian ZZ; Wang HQ; Fu K; Ma YL; Hao XS
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):47-51. PubMed ID: 21429402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.